Leveraging the Medicines for Malaria Venture malaria and pathogen boxes to discover chemical inhibitors of East Coast fever

James Nyagwange1,2, Elias Awino1, Edwin Tijhaar2, Nicholas Svitek1, Roger Pelle3, Vishvanath Nene1
1International Livestock Research Institute, P.O. Box 30709 Nairobi, Kenya
2Cell Biology and Immunology Group, Wageningen University, The Netherlands
3Biosciences Eastern and Central Africa, International Livestock Research Institute (BecA-ILRI) Hub, P. O. Box 30709, Nairobi, Kenya

Tài liệu tham khảo

Baldwin, 1988, Bovine T cells, B cells, and null cells are transformed by the protozoan parasite Theileria parva, Infect. Immun., 56, 462, 10.1128/iai.56.2.462-467.1988 Brown, 1990, Control of tropical theileriosis (Theileria annulata infection) of cattle, Parassitologia, 32, 23 Chen, 2006, Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib), Mol. Pharmacol., 69, 1527, 10.1124/mol.105.020172 Clinical Trials Partnership, 2015, Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial, Lancet (London, England), 386, 31, 10.1016/S0140-6736(15)60721-8 Comer, 2001, 275 Cui, 2015, Antimalarial drug resistance: literature review and activities and findings of the ICEMR network, Am. J. Trop. Med. Hyg., 93, 57, 10.4269/ajtmh.15-0007 Dobbelaere, 2003, Theileria-induced leukocyte transformation, Curr. Opin. Microbiol., 6, 377, 10.1016/S1369-5274(03)00085-7 Duffy, 2017, Screening the Medicines for malaria venture pathogen box across multiple pathogens reclassifies starting points for open-source drug discovery, Antimicrob. Agents Chemother., 61, 10.1128/AAC.00379-17 Fich, 1998, Modulation of enzymatic activity of Src-family kinases in bovine T cells transformed by Theileria parva, Parasitology, 117, 107, 10.1017/S0031182098002832 Finn, 2007, Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro, Breast Canc. Res. Treat., 105, 319, 10.1007/s10549-006-9463-x Hochhaus, 2008, Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib, Leukemia, 22, 1200, 10.1038/leu.2008.84 Hostettler, 2016, In vitro screening of the open source MMV malaria box reveals novel compounds with profound activities against Theileria annulata schizonts, Antimicrob. Agents Chemother., 60, 3301, 10.1128/AAC.02801-15 Jeon, 2003, Gold compound auranofin inhibits IkappaB kinase (IKK) by modifying Cys-179 of IKKbeta subunit, Exp. Mol. Med., 35, 61, 10.1038/emm.2003.9 Johnson, 2010, Phase II study of dasatinib in patients with advanced non–small-cell lung cancer, J. Clin. Oncol., 28, 4609, 10.1200/JCO.2010.30.5474 McHardy, 1985, Antitheilerial activity of BW720C (buparvaquone): a comparison with parvaquone, Res. Vet. Sci., 39, 29, 10.1016/S0034-5288(18)31765-X Metheni, 2015, HIF-1α induction, proliferation and glycolysis of Theileria-infected leukocytes, Cell Microbiol., 17, 467, 10.1111/cmi.12421 Mhadhbi, 2010, In vivo evidence for the resistance of Theileria annulata to buparvaquone, Vet. Parasitol., 169, 241, 10.1016/j.vetpar.2010.01.013 Morrison, 2009, Evolution of the Apicomplexa: where are we now?, Trends Parasitol., 25, 375, 10.1016/j.pt.2009.05.010 Nam, 2007, Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells, Mol. Canc. Therapeut., 6, 1400, 10.1158/1535-7163.MCT-06-0446 Nixon, 2013, Antimalarial pharmacology and therapeutics of atovaquone, J. Antimicrob. Chemother., 68, 977, 10.1093/jac/dks504 Norval, 1992 Oxberry, 2001, Assessment of benzimidazole binding to individual recombinant tubulin isotypes from Haemonchus contortus, Parasitology, 122, 683, 10.1017/S0031182001007788 Palacios, 1982, Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation, J. Immunol., 128, 337, 10.4049/jimmunol.128.1.337 Perry, 2016, The control of East Coast fever of cattle by live parasite vaccination: a science-to-impact narrative, One Health, 2, 103, 10.1016/j.onehlt.2016.07.002 Quintas-Cardama, 2006, Targeting ABL and SRC kinases in chronic myeloid leukemia: experience with dasatinib, Future Oncol. (London, England), 2, 655, 10.2217/14796694.2.6.655 Rigobello, 2005, Effect of auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase, Free Radic. Res., 39, 687, 10.1080/10715760500135391 Salas, 2011, Natural and synthetic naphthoquinones active against trypanosoma cruzi: an initial step towards new drugs for chagas disease, Curr. Med. Chem., 18, 144, 10.2174/092986711793979779 Sharifiyazdi, 2012, Point mutations in the Theileria annulata cytochrome b gene is associated with buparvaquone treatment failure, Vet. Parasitol., 187, 431, 10.1016/j.vetpar.2012.01.016 Shiels, 2006, Alteration of host cell phenotype by Theileria annulata and Theileria parva: mining for manipulators in the parasite genomes, Int. J. Parasitol., 36, 9, 10.1016/j.ijpara.2005.09.002 Steinberg, 2007, Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia, Clin. Therapeut., 29, 2289, 10.1016/j.clinthera.2007.11.005 Talpaz, 2006, Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias, N. Engl. J. Med., 354, 2531, 10.1056/NEJMoa055229 Vaidya, 2000, Atovaquone resistance in malaria parasites, Drug Resist. Updates, 3, 283, 10.1054/drup.2000.0157 Van Voorhis, 2016, Open source drug discovery with the malaria box compound collection for neglected diseases and beyond, PLoS Pathog., 12, e1005763, 10.1371/journal.ppat.1005763 Wampande, 2007, Classical ligands interact with native and recombinant tubulin from Onchocerca volvulus with similar rank order of magnitude, Protein Expr. Purif., 55, 236, 10.1016/j.pep.2007.04.011